Bristol Myers Squibb (BMY)Munich Reinsurance Co Stock Corp in Munich added to its stake +31K shares

348K

Shares reported · +31K vs prior quarter

0.44%

Disclosed portfolio weight

$20M

Reported value

Holdings as of

Jun 30, 2026

Filed

Jul 24, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 27, 2026CongressDisclosed purchase of BMY — reported range $1,001 - $15,000
2. May 7, 2026CongressDisclosed sale of BMY — reported range $15,001 - $50,000

What came next

1. Jul 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
2. Aug 7, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.0%
3. Aug 13, 2026FDAFDA drug approval: Zenbexus
4. Aug 25, 2026InsiderOfficer sold ~$34K of BMY shares in the open market
5. Sep 9, 2026InsiderOfficer sold ~$403K of BMY shares in the open market
6. Oct 2, 2026Government · Federal Register ruleGlobal Benchmark for Efficient Drug Pricing (GLOBE) Model

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Bristol Myers Squibb

For Bristol Myers Squibb, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 45 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BMY page.

How this filing works

• SEC Form 13F

Other disclosures at Bristol Myers Squibb

• SEC Form 4Sep 10, 2026
• SEC Form 144Sep 9, 2026
• SEC Form 4Aug 26, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026

Everything OQRO holds on this company is on its BMY page.